Cardiac Rhythm Management (CRM) Devices Market Size, Share and Industry Analysis Product By (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Regional Forecast, 2020 - 2029 (Includes COVID-19 Business Impact)

                                          
We have updated Cardiac Rhythm Management (CRM) Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Cardiac Rhythm Management (CRM) Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Cardiac Rhythm Management (CRM) Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Cardiac Rhythm Management (CRM) Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Cardiac Rhythm Management (CRM) Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Cardiac Rhythm Management (CRM) Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Medtronic and Boston Scientific Corporation to Account for More Than Half of the Market Share in Terms of Revenue

Medtronic is a leading player in the global implantable cardioverter defibrillator market. Combined with this, Medtronic also holds a considerable share of the global pacemaker market. Medtronic is anticipated to retain its leading position in the forecast duration owing to its wide range of product offerings, availability of products across the globe and strong customer base. This company, together with Boston Scientific Corporation, currently holds over half of the market share in terms of revenue. Other players operating in the global  market are Cardiac Science, Physio Control, Stryker, Defibtech, LLC., CU Medical Systems Inc., Abbott, Boston Scientific Corporation, LivaNova PLC, MicroPort, BIOTRONIK, and others.

Key Market Players

  
Medtronic
  
Boston Scientific Corporation
  
Biotronik
  
Asahi Kasei Corporation
  
Philips Healthcare
  
Defibtech, LLC.
  
Cardiac Science
  
Stryker
  
CU Medical System Inc.
  
LivaNova Plc
  
Abbott
  
Microport
  
Other prominent players

Report Coverage

Cardiac rhythm management devices are widely used to treat heart disease and heart rhythm disorders across the globe. Implantable cardioverter defibrillators and pacemakers play a major role in managing heart rhythm.

Combined with this, these devices perform other important functions such as bradycardia pacing, defibrillation, and anti-tachycardia pacing. Dramatically increasing prevalence of cardiac conditions and proven efficiency of these  devices to treat such conditions is anticipated to offer huge potential for growth of the global  market by 2026.

The cardiac rhythm management devices market report provides qualitative and quantitative insights on the  industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented by product, by the end user, and by region. On the basis of the product, the CRM devices market is segmented into cardiac pacemakers, defibrillators, and cardiac resynchronization devices. Cardiac pacemakers are further segmented into single chamber pacemakers and dual chamber pacemakers. Defibrillators are further segmented into external defibrillators and implantable defibrillators. Cardiac resynchronization therapy devices are categorized into CRT-P and CRT-D. Various end users covered under the report are hospitals & clinics and ambulatory surgery centers and others. Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the World. The regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of sudden cardiac arrests in key countries, technological advancements in cardiac rhythm management devices, recent industry developments such as mergers & acquisitions, the regulatory scenario in key countries, new products launches, reimbursement scenario, and key industry trends.

Segmentation

Segmentation

By Product

  
Cardiac Pacemakers
  
Single Chamber Pacemakers
  
Dual Chamber Pacemakers
  
Defibrillators
  
Implantable Cardioverter Defibrillators (ICD)
  
Single Chamber ICD
  
Dual Chamber ICD
  
External Defibrillators
  
Automated External Defibrillators
  
Manual & Semi-Automatic External Defibrillators
  
Wearable DefibrillatorsCardiac Resynchronization Therapy Devices
  
CRT-PCRT-D

By End User

  
Hospitals & Clinics
  
Ambulatory Surgery Centers and Others

By Geography

  
North America (the USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Rest of the World

 Key Industry Developments

In March 2019, Biotronik launched MRI compatible ICD and CRT-D system in Europe market.

In November 2017, Medtronic got FDA approval for their Azure pacemakers. These newly developed pacemakers are equipped with BlueSync technology which enables device longevity and improved patient monitoring.

In July 2017, Biotronik launched Evity cardiac resynchronization therapy pacemaker (CRT-P) in Japan market. According to company estimates, it is the highest performing CRT-P with battery life of 10 years.